Peking University: Stomach Neoplasms trials

The registry lists 42 Stomach Neoplasms studies with Peking University as lead sponsor. 10 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 16Phase 3 3No phase 21(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• ctDNA-MRD Monitoring After Resection in Gastric CancerRecruitingNCT06893133
• Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon CancersRecruitingNCT06580574Phase 2
• The Effect of MDT Plus SDM on Survival Benefit of Advanced Gastric CancerRecruitingNCT06432205
• Financial Incentives and Motivational Intervention to Improve Gastric Cancer Screening in ChinaNot yet recruitingNCT06384300Not applicable
• Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJANot yet recruitingNCT06222944Phase 2
• NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid TumorRecruitingNCT06134960Phase 1
• Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GCRecruitingNCT06023758Phase 2
• Selecting Patients Who May Benefit From Immunotherapy by Tissue-based Biomarkers.RecruitingNCT05593419
• Laparoscopic Versus Open Lower Mediastinal Lymphadenectomy for Esophagogastric Junction CancerRecruitingNCT04443478
• The Analysis of Immuno-Nutrition Index in Advanced Gastric Cancer Receiving Preoperative TreatmentsRecruitingNCT03493880
• Dynamic Multiomics Evaluation of Anti-HER2 and Immunotherapy in HER2 Positive Gastric CancerStatus unknownNCT05348161Not applicable
• Evaluation of HER2-targeted Therapy for Gastric Cancer and Establishment and Verification of Monitoring SystemStatus unknownNCT05165602
• Tislelizumab Plus Anlotinib for Immunotherapy Resistant Gastrointestinal CancerStatus unknownNCT04777162Phase 2
• Study of Camrelizumab (SHR-1210) and Apatinb Based Therapies for Alpha-fetoprotein (AFP)-Producing Gastric Cancer or Gastroesophageal Junction AdenocarcinomaStatus unknownNCT04609176Phase 2
• A Study to Confirm the Accuracy of Locally Advanced Gastric Cancer DiagnosisStatus unknownNCT04440605
• Study on the Effectiveness of Gastroscope Operation Quality Control Based on Artificial Intelligence TechnologyCompletedNCT04384575
• Function Preserving Gastrectomy for T1/2 Gastric Cancer PatientsStatus unknownNCT03874871
• Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric CancerStatus unknownNCT03575637Phase 2
• Laparoscopic Versus Open Gastrectomy for Elderly Local Advanced Gastric Cancer PatientsStatus unknownNCT03564834Phase 2
• Study to Evaluate SHR6390 Combined With Pyrotinib in Patients With HER2 Positive Gastric CancerStatus unknownNCT03480256Phase 1
• Real World Evidence for the Cycle of Neoadjuvant Chemotherapy in Gastric Cancer With Shared Decision MakingStatus unknownNCT03413514Not applicable
• Study of Nimotuzumab and Irinotecan as Second Line With Recurrent or Metastatic Gastric AdenocarcinomaStatus unknownNCT03400592Phase 2
• The Origin of Infrapyloric ArteryCompletedNCT03071237
• Treatment Strategy for Stage IV Gastric Cancer with Positive Peritoneal Cytology As the Only Non-curable FactorTerminatedNCT02969122Not applicable
• Liquid Biopsy in Monitoring the Therapeutic Efficacy of Targeted Therapy in Advanced/Metastatic Gastric CancerStatus unknownNCT02610218
• A Comparison of Laparoscopic With Open Distal Gastrectomy in Advanced Gastric Cancer After Neoadjuvant ChemotherapyStatus unknownNCT02404753Phase 2
• Early Palliative Care in Metastatic Esophageal Squamous Carcinoma (ESCC) and Gastric CancerStatus unknownNCT02375997Phase 3
• Compare Different Response Evaluations to Neoadjuvant Chemotherapy for Gastric CancerStatus unknownNCT02179463
• Laparoscopic Staging for Locally Advanced Gastric Cancer in Chinese PatientsCompletedNCT02172690Not applicable
• Study on Neoadjuvant Chemotherapy for Advanced Gastric CancerStatus unknownNCT02163291Phase 2
• Clinical Study on the Harvesting Lymph Nodes With Carbon Nanoparticles for Advanced Gastric CancerStatus unknownNCT02123407Phase 3
• Circulating Tumor Cells (CTCs) in Advanced Gastric CancerStatus unknownNCT01848015
• HER2 Positive CTC in Advanced Gastric CancerStatus unknownNCT01847794Not applicable
• A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 SurgeryStatus unknownNCT01679340Phase 2
• Clinical Significance of Circulating Tumor Cells (CTCs) in Blood of Patients With Advanced/Metastatic Gastric CancerCompletedNCT01625702Not applicable
• Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 DissectionStatus unknownNCT01534546Phase 3
• A Prospective and Observational Cohort Study to Evaluate the Treatment Model and Medical Economics of Advanced Gastric Cancer Chemotherapy in Clinical Practice in ChinaCompletedNCT01472250
• Sequential HIPEC of Oxaliplatin and Paclitaxel for Gastric Cancer Patients With Peritoneum MetastasisStatus unknownNCT01471132Phase 2
• A Study to Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric CancerCompletedNCT01364493Phase 2
• Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric CancerCompletedNCT00842491Phase 2
• Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric CancerStatus unknownNCT00591045Phase 2
• A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric CancerCompletedNCT00477711Phase 2